| dc.contributor.author | Paschou, SA | en_US |
| dc.contributor.author | Leslie, RD | en_US |
| dc.date.accessioned | 2017-05-16T09:42:30Z | |
| dc.date.available | 2013-06-11 | en_US |
| dc.date.issued | 2013-07-10 | en_US |
| dc.date.submitted | 2017-03-30T11:23:56.734Z | |
| dc.identifier.issn | 1741-7015 | en_US |
| dc.identifier.other | ARTN 161 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23121 | |
| dc.description.sponsorship | Action LADA programme within the 5th Framework Programme of the EU | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | BMC MEDICINE | en_US |
| dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
| dc.subject | Type 2 diabetes | en_US |
| dc.subject | Guidelines | en_US |
| dc.subject | Personalised treatment | en_US |
| dc.subject | Diabetes management | en_US |
| dc.subject | Patient-centered therapy | en_US |
| dc.title | Personalizing guidelines for diabetes management: twilight or dawn of the expert? | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2013 Paschou and Leslie; licensee BioMed Central Ltd. | |
| dc.identifier.doi | 10.1186/1741-7015-11-161 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000321857300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 11 | en_US |
